Modulation of the antibody response to the HIV envelope subunit by co-administration of infectious or heat-inactivated canarypoxvirus (ALVAC) preparations

被引:10
作者
Boudet, F
Chevalier, M
Jourdier, TM
Tartaglia, J
Moste, C
机构
[1] Aventis Pasteur, F-69280 Marcy Letoile, France
[2] Aventis Pasteur, Willowdale, ON M2R 3T4, Canada
关键词
inflammation; immunomodulation; ALVAC canarypoxvirus;
D O I
10.1016/S0264-410X(01)00150-5
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Poxviruses are large DNA viruses capable of infecting a broad range of animal species. Infection is generally accompanied by an inflammatory response in the host, the extent of which varies considerably with the specific poxvirus and host species. Regarding ALVAC, a poxvirus derived from the canarypox vaccine strain, Kanapox, and which represents a promising immunization vehicle in humans, nothing is known about its inflammatory capacity. The present study was aimed at documenting this issue in rodents, including mice and guinea pigs. It was then attempted to evaluate how such properties could influence the immunogenicity of an antigen concomitantly administered with ALVAC preparations using the HIV envelope subunit, rgp160, as the model immunogen. The results revealed that ALVAC, either infectious or heat-inactivated, induced in both animal species an early inflammatory response, as evidenced by a rapid migration of neutrophils to the site of inoculation. In parallel, the canarypoxvirus was shown to strongly adjuvant the co-administered immunogen, resulting in a marked increase in Env-specific IgG, IgGl and particularly IgG2(a) serum titers. Of further interest, the heat-inactivated preparation of ALVAC retained this immunostimulatory activity. Whether or not a link between the inflammatory and immunomodulatory properties of ALVAC exists remains to be established, but such features are clearly interesting with respect to the potential use of ALVAC as an immunization vehicle. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:4267 / 4275
页数:9
相关论文
共 34 条
[1]   Poxviruses:: Capturing cytokines and chemokines [J].
Alcamí, A ;
Symons, JA ;
Khanna, A ;
Smith, GL .
SEMINARS IN VIROLOGY, 1998, 8 (05) :419-427
[2]   SAPONIN AND OTHER HEMOLYSINS (VITAMIN-A, ALIPHATIC-AMINES, POLYENE ANTIBIOTICS) AS ADJUVANTS FOR SRBC IN THE MOUSE - EVIDENCE FOR A ROLE FOR CHOLESTEROL-BINDING IN SAPONIN ADJUVANTICITY [J].
BOMFORD, R .
INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1980, 63 (02) :170-177
[3]   Construction and characterisation of a recombinant vaccinia was expressing human papillomavirus proteins for immunotherapy of cervical cancer [J].
Boursnell, MEG ;
Rutherford, E ;
Hickling, JK ;
Rollinson, EA ;
Munro, AJ ;
Rolley, N ;
McLean, CS ;
Borysiewicz, LK ;
Vousden, K ;
Inglis, SC .
VACCINE, 1996, 14 (16) :1485-1494
[4]   POXVIRUS PATHOGENESIS [J].
BULLER, RML ;
PALUMBO, GJ .
MICROBIOLOGICAL REVIEWS, 1991, 55 (01) :80-122
[5]   INTERFERON INDUCTION IN PERIPHERAL-BLOOD MONONUCLEAR LEUKOCYTES OF MAN AND FARM-ANIMALS BY POXVIRUS VECTOR CANDIDATES AND SOME POXVIRUS CONSTRUCTS [J].
BUTTNER, M ;
CZERNY, CP ;
LEHNER, KH ;
WERTZ, K .
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 1995, 46 (3-4) :237-250
[6]   IMMUNIZATION WITH CANARYPOX VIRUS EXPRESSING RABIES GLYCOPROTEIN [J].
CADOZ, M ;
STRADY, A ;
MEIGNIER, B ;
TAYLOR, J ;
TARTAGLIA, J ;
PAOLETTI, E ;
PLOTKIN, S .
LANCET, 1992, 339 (8807) :1429-1432
[7]  
CICCO NA, 1990, BLOOD, V75, P2049
[8]  
Excler JL, 1997, AIDS, V11, pS127
[9]   Poxvirus-induced immunostimulating effects on porcine leukocytes [J].
Fachinger, V ;
Schlapp, T ;
Strube, W ;
Schmeer, N ;
Saalmüller, A .
JOURNAL OF VIROLOGY, 2000, 74 (17) :7943-7951
[10]   Activation of human T cells by major histocompatability complex class II expressing neutrophils: Proliferation in the presence of superantigen, but not tetanus toxoid [J].
Fanger, NA ;
Liu, CL ;
Guyre, PM ;
Wardwell, K ;
ONeil, J ;
Guo, TL ;
Christian, TP ;
Mudzinski, SP ;
Gosselin, EJ .
BLOOD, 1997, 89 (11) :4128-4135